Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT04499534

BRCA1/2 Flu Vaccine

Sponsor: Abramson Cancer Center at Penn Medicine

View on ClinicalTrials.gov

Summary

To evaluate immune function in BRCA1/2 mutation carriers without cancer, specifically to determine whether immune function in healthy individuals with germline loss of function BRCA1/2 mutations, impacts overall immune health and fitness.

Official title: Influenza Vaccine Study in BRCA1 or BRCA2 Carriers

Key Details

Gender

All

Age Range

25 Years - Any

Study Type

OBSERVATIONAL

Enrollment

50

Start Date

2019-10-28

Completion Date

2026-06

Last Updated

2025-10-06

Healthy Volunteers

Yes

Interventions

BIOLOGICAL

Seasonal influenza vaccine

To evaluate immune function in BRCA1/2 mutation carriers without cancer following seasonal influenza vaccination

Locations (1)

University of Pennsylvania

Philadelphia, Pennsylvania, United States